Theranica
The company had previously received FDA clearance to use its prescription wearable to treat migraines at onset.
The startup plans to use the funding to expand in the U.S.
Nerivio is a wireless, noninvasive remote electrical-stimulation wearable that is worn on the upper arm at the onset of a migraine.
The round was led by health tech and life sciences VC fund aMoon.
The agency also warned consumers of unregulated diabetes products and outlined plans for AI device regulation.
An interview with Tomoko Inoue, CEO of OMRON Ventures.